KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 98 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $650 | -67.7% | 34,839 | -65.9% | 0.00% | – |
| Q1 2024 | $2,015 | -50.0% | 102,147 | -55.5% | 0.00% | -100.0% |
| Q4 2023 | $4,030 | +32.2% | 229,756 | +30.9% | 0.00% | -50.0% |
| Q3 2023 | $3,048 | +33.0% | 175,525 | +7.9% | 0.00% | +100.0% |
| Q2 2023 | $2,291 | +31.3% | 162,658 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $1,745 | +94.1% | 162,179 | +170.3% | 0.00% | – |
| Q4 2022 | $899 | -99.7% | 60,007 | +168.6% | 0.00% | – |
| Q3 2022 | $287,000 | +81.6% | 22,341 | +36.5% | 0.00% | – |
| Q2 2022 | $158,000 | -19.0% | 16,372 | -16.7% | 0.00% | – |
| Q1 2022 | $195,000 | -85.1% | 19,661 | -82.3% | 0.00% | – |
| Q4 2021 | $1,306,000 | +49.8% | 111,068 | +45.1% | 0.00% | – |
| Q3 2021 | $872,000 | +217.1% | 76,560 | +286.1% | 0.00% | – |
| Q2 2021 | $275,000 | -94.2% | 19,829 | -92.2% | 0.00% | -100.0% |
| Q1 2021 | $4,729,000 | -60.7% | 255,536 | -62.5% | 0.00% | -50.0% |
| Q4 2020 | $12,031,000 | +172.4% | 680,900 | +136.1% | 0.01% | +100.0% |
| Q3 2020 | $4,417,000 | +944.2% | 288,388 | +1638.1% | 0.00% | – |
| Q2 2020 | $423,000 | +336.1% | 16,592 | +166.5% | 0.00% | – |
| Q1 2020 | $97,000 | -52.0% | 6,225 | -66.0% | 0.00% | – |
| Q4 2019 | $202,000 | +106.1% | 18,283 | +60.1% | 0.00% | – |
| Q3 2019 | $98,000 | -35.1% | 11,419 | +2.4% | 0.00% | – |
| Q2 2019 | $151,000 | +88.8% | 11,155 | +155.6% | 0.00% | – |
| Q1 2019 | $80,000 | -7.0% | 4,365 | +42.9% | 0.00% | – |
| Q4 2018 | $86,000 | +38.7% | 3,054 | +25.7% | 0.00% | – |
| Q3 2018 | $62,000 | – | 2,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |